世界の上皮性卵巣がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Epithelial Ovarian Cancer Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4200 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、上皮性卵巣がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（手術、化学療法、放射線療法）、用途別市場規模（病院、外来外科センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・上皮性卵巣がん治療の市場動向 ・企業の競争状況、市場シェア ・上皮性卵巣がん治療の種類別市場規模と予測2016-2027（手術、化学療法、放射線療法） ・上皮性卵巣がん治療の用途別市場規模と予測2016-2027（病院、外来外科センター、その他） ・上皮性卵巣がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・上皮性卵巣がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・上皮性卵巣がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・上皮性卵巣がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・上皮性卵巣がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（C. H. Boehringer Sohn、Takeda、Amgen、ImmunoGen、AbbVie、Bayer、Synta Pharmaceuticals、Prima BioMed、Oasmia Pharmaceutical、Glycotope） ・結論

Epithelial ovarian cancer is a disease in which malignant cells develop in the tissue that covers the ovary. Epithelial ovarian cancer is common in women who have a close relation such as mother, daughter, or sister diagnosed with the disease.

Market Analysis and Insights: Global Epithelial Ovarian Cancer Treatment Market
The global Epithelial Ovarian Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epithelial Ovarian Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epithelial Ovarian Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epithelial Ovarian Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epithelial Ovarian Cancer Treatment market.

Global Epithelial Ovarian Cancer Treatment Scope and Market Size
Epithelial Ovarian Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epithelial Ovarian Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Surgery
Chemotherapy
Radiation Therapy

Segment by Application
Hospitals
Ambulatory Surgical Center
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
C. H. Boehringer Sohn
Takeda
Amgen
ImmunoGen
AbbVie
Bayer
Synta Pharmaceuticals
Prima BioMed
Oasmia Pharmaceutical
Glycotope

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epithelial Ovarian Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Chemotherapy
1.2.4 Radiation Therapy
1.3 Market by Application
1.3.1 Global Epithelial Ovarian Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Epithelial Ovarian Cancer Treatment Market Perspective (2016-2027)
2.2 Epithelial Ovarian Cancer Treatment Growth Trends by Regions
2.2.1 Epithelial Ovarian Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Epithelial Ovarian Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Epithelial Ovarian Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Epithelial Ovarian Cancer Treatment Industry Dynamic
2.3.1 Epithelial Ovarian Cancer Treatment Market Trends
2.3.2 Epithelial Ovarian Cancer Treatment Market Drivers
2.3.3 Epithelial Ovarian Cancer Treatment Market Challenges
2.3.4 Epithelial Ovarian Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Epithelial Ovarian Cancer Treatment Players by Revenue
3.1.1 Global Top Epithelial Ovarian Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Epithelial Ovarian Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Epithelial Ovarian Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Epithelial Ovarian Cancer Treatment Revenue
3.4 Global Epithelial Ovarian Cancer Treatment Market Concentration Ratio
3.4.1 Global Epithelial Ovarian Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epithelial Ovarian Cancer Treatment Revenue in 2020
3.5 Epithelial Ovarian Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Epithelial Ovarian Cancer Treatment Product Solution and Service
3.7 Date of Enter into Epithelial Ovarian Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Epithelial Ovarian Cancer Treatment Breakdown Data by Type
4.1 Global Epithelial Ovarian Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Epithelial Ovarian Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Epithelial Ovarian Cancer Treatment Breakdown Data by Application
5.1 Global Epithelial Ovarian Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Epithelial Ovarian Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Epithelial Ovarian Cancer Treatment Market Size (2016-2027)
6.2 North America Epithelial Ovarian Cancer Treatment Market Size by Type
6.2.1 North America Epithelial Ovarian Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Epithelial Ovarian Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Epithelial Ovarian Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Epithelial Ovarian Cancer Treatment Market Size by Application
6.3.1 North America Epithelial Ovarian Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Epithelial Ovarian Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Epithelial Ovarian Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Epithelial Ovarian Cancer Treatment Market Size by Country
6.4.1 North America Epithelial Ovarian Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Epithelial Ovarian Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Epithelial Ovarian Cancer Treatment Market Size (2016-2027)
7.2 Europe Epithelial Ovarian Cancer Treatment Market Size by Type
7.2.1 Europe Epithelial Ovarian Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Epithelial Ovarian Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Epithelial Ovarian Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Epithelial Ovarian Cancer Treatment Market Size by Application
7.3.1 Europe Epithelial Ovarian Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Epithelial Ovarian Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Epithelial Ovarian Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Epithelial Ovarian Cancer Treatment Market Size by Country
7.4.1 Europe Epithelial Ovarian Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Epithelial Ovarian Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Epithelial Ovarian Cancer Treatment Market Size (2016-2027)
9.2 Latin America Epithelial Ovarian Cancer Treatment Market Size by Type
9.2.1 Latin America Epithelial Ovarian Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Epithelial Ovarian Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Epithelial Ovarian Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Epithelial Ovarian Cancer Treatment Market Size by Application
9.3.1 Latin America Epithelial Ovarian Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Epithelial Ovarian Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Epithelial Ovarian Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Epithelial Ovarian Cancer Treatment Market Size by Country
9.4.1 Latin America Epithelial Ovarian Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Epithelial Ovarian Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 C. H. Boehringer Sohn
11.1.1 C. H. Boehringer Sohn Company Details
11.1.2 C. H. Boehringer Sohn Business Overview
11.1.3 C. H. Boehringer Sohn Epithelial Ovarian Cancer Treatment Introduction
11.1.4 C. H. Boehringer Sohn Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021)
11.1.5 C. H. Boehringer Sohn Recent Development
11.2 Takeda
11.2.1 Takeda Company Details
11.2.2 Takeda Business Overview
11.2.3 Takeda Epithelial Ovarian Cancer Treatment Introduction
11.2.4 Takeda Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021)
11.2.5 Takeda Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Epithelial Ovarian Cancer Treatment Introduction
11.3.4 Amgen Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021)
11.3.5 Amgen Recent Development
11.4 ImmunoGen
11.4.1 ImmunoGen Company Details
11.4.2 ImmunoGen Business Overview
11.4.3 ImmunoGen Epithelial Ovarian Cancer Treatment Introduction
11.4.4 ImmunoGen Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021)
11.4.5 ImmunoGen Recent Development
11.5 AbbVie
11.5.1 AbbVie Company Details
11.5.2 AbbVie Business Overview
11.5.3 AbbVie Epithelial Ovarian Cancer Treatment Introduction
11.5.4 AbbVie Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021)
11.5.5 AbbVie Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Epithelial Ovarian Cancer Treatment Introduction
11.6.4 Bayer Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Synta Pharmaceuticals
11.7.1 Synta Pharmaceuticals Company Details
11.7.2 Synta Pharmaceuticals Business Overview
11.7.3 Synta Pharmaceuticals Epithelial Ovarian Cancer Treatment Introduction
11.7.4 Synta Pharmaceuticals Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021)
11.7.5 Synta Pharmaceuticals Recent Development
11.8 Prima BioMed
11.8.1 Prima BioMed Company Details
11.8.2 Prima BioMed Business Overview
11.8.3 Prima BioMed Epithelial Ovarian Cancer Treatment Introduction
11.8.4 Prima BioMed Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021)
11.8.5 Prima BioMed Recent Development
11.9 Oasmia Pharmaceutical
11.9.1 Oasmia Pharmaceutical Company Details
11.9.2 Oasmia Pharmaceutical Business Overview
11.9.3 Oasmia Pharmaceutical Epithelial Ovarian Cancer Treatment Introduction
11.9.4 Oasmia Pharmaceutical Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021)
11.9.5 Oasmia Pharmaceutical Recent Development
11.10 Glycotope
11.10.1 Glycotope Company Details
11.10.2 Glycotope Business Overview
11.10.3 Glycotope Epithelial Ovarian Cancer Treatment Introduction
11.10.4 Glycotope Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021)
11.10.5 Glycotope Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Epithelial Ovarian Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Radiation Therapy
Table 5. Global Epithelial Ovarian Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Epithelial Ovarian Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Epithelial Ovarian Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Epithelial Ovarian Cancer Treatment Market Share by Regions (2016-2021)
Table 9. Global Epithelial Ovarian Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Epithelial Ovarian Cancer Treatment Market Share by Regions (2022-2027)
Table 11. Epithelial Ovarian Cancer Treatment Market Trends
Table 12. Epithelial Ovarian Cancer Treatment Market Drivers
Table 13. Epithelial Ovarian Cancer Treatment Market Challenges
Table 14. Epithelial Ovarian Cancer Treatment Market Restraints
Table 15. Global Epithelial Ovarian Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Epithelial Ovarian Cancer Treatment Market Share by Players (2016-2021)
Table 17. Global Top Epithelial Ovarian Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epithelial Ovarian Cancer Treatment as of 2020)
Table 18. Ranking of Global Top Epithelial Ovarian Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Epithelial Ovarian Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Epithelial Ovarian Cancer Treatment Product Solution and Service
Table 22. Date of Enter into Epithelial Ovarian Cancer Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Epithelial Ovarian Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Epithelial Ovarian Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Epithelial Ovarian Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Epithelial Ovarian Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Epithelial Ovarian Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Epithelial Ovarian Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Epithelial Ovarian Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Epithelial Ovarian Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Epithelial Ovarian Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Epithelial Ovarian Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Epithelial Ovarian Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Epithelial Ovarian Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Epithelial Ovarian Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Epithelial Ovarian Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Epithelial Ovarian Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Epithelial Ovarian Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Epithelial Ovarian Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Epithelial Ovarian Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Epithelial Ovarian Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Epithelial Ovarian Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Epithelial Ovarian Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Epithelial Ovarian Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Epithelial Ovarian Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Epithelial Ovarian Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Epithelial Ovarian Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Epithelial Ovarian Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. C. H. Boehringer Sohn Company Details
Table 63. C. H. Boehringer Sohn Business Overview
Table 64. C. H. Boehringer Sohn Epithelial Ovarian Cancer Treatment Product
Table 65. C. H. Boehringer Sohn Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021) & (US$ Million)
Table 66. C. H. Boehringer Sohn Recent Development
Table 67. Takeda Company Details
Table 68. Takeda Business Overview
Table 69. Takeda Epithelial Ovarian Cancer Treatment Product
Table 70. Takeda Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021) & (US$ Million)
Table 71. Takeda Recent Development
Table 72. Amgen Company Details
Table 73. Amgen Business Overview
Table 74. Amgen Epithelial Ovarian Cancer Treatment Product
Table 75. Amgen Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021) & (US$ Million)
Table 76. Amgen Recent Development
Table 77. ImmunoGen Company Details
Table 78. ImmunoGen Business Overview
Table 79. ImmunoGen Epithelial Ovarian Cancer Treatment Product
Table 80. ImmunoGen Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021) & (US$ Million)
Table 81. ImmunoGen Recent Development
Table 82. AbbVie Company Details
Table 83. AbbVie Business Overview
Table 84. AbbVie Epithelial Ovarian Cancer Treatment Product
Table 85. AbbVie Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021) & (US$ Million)
Table 86. AbbVie Recent Development
Table 87. Bayer Company Details
Table 88. Bayer Business Overview
Table 89. Bayer Epithelial Ovarian Cancer Treatment Product
Table 90. Bayer Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021) & (US$ Million)
Table 91. Bayer Recent Development
Table 92. Synta Pharmaceuticals Company Details
Table 93. Synta Pharmaceuticals Business Overview
Table 94. Synta Pharmaceuticals Epithelial Ovarian Cancer Treatment Product
Table 95. Synta Pharmaceuticals Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021) & (US$ Million)
Table 96. Synta Pharmaceuticals Recent Development
Table 97. Prima BioMed Company Details
Table 98. Prima BioMed Business Overview
Table 99. Prima BioMed Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021) & (US$ Million)
Table 100. Prima BioMed Recent Development
Table 101. Oasmia Pharmaceutical Company Details
Table 102. Oasmia Pharmaceutical Business Overview
Table 103. Oasmia Pharmaceutical Epithelial Ovarian Cancer Treatment Product
Table 104. Oasmia Pharmaceutical Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021) & (US$ Million)
Table 105. Oasmia Pharmaceutical Recent Development
Table 106. Glycotope Company Details
Table 107. Glycotope Business Overview
Table 108. Glycotope Epithelial Ovarian Cancer Treatment Product
Table 109. Glycotope Revenue in Epithelial Ovarian Cancer Treatment Business (2016-2021) & (US$ Million)
Table 110. Glycotope Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epithelial Ovarian Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Chemotherapy Features
Figure 4. Radiation Therapy Features
Figure 5. Global Epithelial Ovarian Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Center Case Studies
Figure 8. Others Case Studies
Figure 9. Epithelial Ovarian Cancer Treatment Report Years Considered
Figure 10. Global Epithelial Ovarian Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Epithelial Ovarian Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Epithelial Ovarian Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Epithelial Ovarian Cancer Treatment Market Share by Regions (2022-2027)
Figure 14. Global Epithelial Ovarian Cancer Treatment Market Share by Players in 2020
Figure 15. Global Top Epithelial Ovarian Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epithelial Ovarian Cancer Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Epithelial Ovarian Cancer Treatment Revenue in 2020
Figure 17. Global Epithelial Ovarian Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Epithelial Ovarian Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Epithelial Ovarian Cancer Treatment Market Share by Type (2016-2027)
Figure 21. North America Epithelial Ovarian Cancer Treatment Market Share by Application (2016-2027)
Figure 22. North America Epithelial Ovarian Cancer Treatment Market Share by Country (2016-2027)
Figure 23. United States Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Epithelial Ovarian Cancer Treatment Market Share by Type (2016-2027)
Figure 27. Europe Epithelial Ovarian Cancer Treatment Market Share by Application (2016-2027)
Figure 28. Europe Epithelial Ovarian Cancer Treatment Market Share by Country (2016-2027)
Figure 29. Germany Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Epithelial Ovarian Cancer Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Epithelial Ovarian Cancer Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Epithelial Ovarian Cancer Treatment Market Share by Region (2016-2027)
Figure 39. China Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Epithelial Ovarian Cancer Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Epithelial Ovarian Cancer Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Epithelial Ovarian Cancer Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Epithelial Ovarian Cancer Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Epithelial Ovarian Cancer Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Epithelial Ovarian Cancer Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Epithelial Ovarian Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. C. H. Boehringer Sohn Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2016-2021)
Figure 59. Takeda Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2016-2021)
Figure 60. Amgen Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2016-2021)
Figure 61. ImmunoGen Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2016-2021)
Figure 62. AbbVie Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2016-2021)
Figure 63. Bayer Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2016-2021)
Figure 64. Synta Pharmaceuticals Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2016-2021)
Figure 65. Prima BioMed Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2016-2021)
Figure 66. Oasmia Pharmaceutical Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2016-2021)
Figure 67. Glycotope Revenue Growth Rate in Epithelial Ovarian Cancer Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---